X-37
X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover novel drug candidates by screening vast libraries of chemical compounds against high-value pharmaceutical targets.
X-37
Industry:
Artificial Intelligence Health Care Pharmaceutical
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.x37.ai
Total Employee:
1+
Status:
Active
Contact:
(650) 273-5748
Email Addresses:
[email protected]
Total Funding:
14.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag
Similar Organizations
Current Employees Featured
Founder
Investors List
Hemi Ventures
Hemi Ventures investment in Series A - X-37
DCVC Bio
DCVC Bio investment in Series A - X-37
Alpha Intelligence Capital
Alpha Intelligence Capital investment in Series A - X-37
DCVC Bio
DCVC Bio investment in Seed Round - X-37
Official Site Inspections
http://www.x37.ai
- Host name: 209.182.198.8
- IP address: 209.182.198.8
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "X-37"
X37 is Drug Development At The Speed of AI
Our AI-driven approach to drug development lets us work on the most difficult-to-target proteins across the broadest possible chemical space. We focus on targets of high therapeutic value that have challenged the conventional drug …See details»
X-37 - Crunchbase Company Profile & Funding
X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover …See details»
X-37 2025 Company Profile: Valuation, Funding & Investors
X-37 General Information Description. Developer of a drug development platform designed to facilitate the discovery of various medicines for patients. The company's platform uses artificial …See details»
New Atomwise offshoot X-37 raises $14.5M to …
Nov 14, 2019 In addition to targets such as ZAP-70 in autoimmune disease, PIM3 and SHP2 in cancer and coagulation factor XIIa, X-37 will use …See details»
X-37 - LinkedIn
Employees at X-37 Vinit B. Mahajan Stanford University Professor of Ophthalmology, Vice Chair for Research, Biotechnology Consultant, Co-founder, Member of Startup Advisory Boards…See details»
X-37 - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 22, 2025 X-37 - Developer of drugs for cancer, autoimmune diseases and anticoaguulation using AI technology. Raised a total funding of $14.5M over 1 round from 4 investors. Founded …See details»
X-37 Company Profile - Office Locations, Competitors, Revenue
X-37 is a pharmaceutical discovery and development company. It uses an AI platform to discover drug candidates by screening libraries of chemical compounds against pharmaceutical targets. …See details»
X-37 - Funding, Financials, Valuation & Investors - Crunchbase
X-37 is a pharmaceutical discovery and development company. New. ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AI . Organization. …See details»
X37 / X-37 | AI Drug Development By Industry Professionals - X37
X37.ai has an estimated worth of US$ 13,206, based on its estimated Ads revenue. X37.ai receives approximately 1,206 unique visitors each day. Its web server is located in Los …See details»
X-37 | F6S
X-37 - AI (Artificial Intelligence) - Drug Development at the Speed of AI Claim the X-37 page . Claim page This page was created when someone associated with X-37 joined F6S. Verified …See details»
X-37’s Competitors, Revenue, Number of Employees, Funding
X-37’s Profile, Revenue and Employees. X-37 is an artificial intelligence-enabled drug discovery company that develops molecules for the treatment of cancer and tumor. X-37’s primary …See details»
X-37 Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for X-37. See X-37 company profile and funding data.See details»
x37.ai - Home | - X 37 - Sur.ly
X-37 | AI Drug Development By Industry Professionals - X37. We use AI to discover better medicines faster -- then our team of industry veterans rapidly takes those candidates into …See details»
X-37 Closes $14.5 Million Financing for AI-Enabled Drug Discovery
Nov 14, 2019 Artificial intelligence-enabled drug discovery startup X-37, LLC, announced it has closed $14.5 million in Series A funding to expand its drug development programs and …See details»
X-37 - VentureRadar
" X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc., to screen vast libraries of chemical compounds …See details»
X-37 - Company info. interviews, news - biopharmatrend.com
X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover novel drug candidates by screening …See details»
API Organization Verification - OpenAI Help Center
Details about how to verify your API organization to unlock use of our most advanced models in the API. ... At OpenAI, we take our responsibility seriously to ensure that AI is both broadly …See details»
X-37 | Golden
X-37 is a South San Francisco, California-based drug discovery company. ... x37.ai. Is a. Organization. Company. Company attributes. Industry. Healthcare. Biomedical engineering. …See details»
Dynamic Org Charts: How AI Will Transform Organizational Design
1 day ago Data integration: AI will pull information from multiple systems (HR databases, project management tools, communication platforms) to create a unified view of the organization. …See details»
Foundation AI: The Intelligent Future of Cybersecurity
Apr 28, 2025 Today, we are thrilled to announce the launch of Foundation AI, a Cisco organization dedicated to creating open bleeding-edge AI technology to empower …See details»